comparemela.com
Home
Live Updates
BridgeBio to Host Call on Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondroplasia on June 4, 2024 : comparemela.com
BridgeBio to Host Call on Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondroplasia on June 4, 2024
PALO ALTO, Calif., June 03, 2024 -- BridgeBio Pharma, Inc. , a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of its management team, along...
Related Keywords
Melbourne ,
Victoria ,
Australia ,
Ravi Savarirayan ,
Vikram Bali ,
Nasdaq ,
Linkedin ,
Twitter ,
Bridgebio Pharma Inc ,
Bio Pharma Inc ,
Murdoch Children Research Institute ,
Bio Pharma ,
Murdoch Children ,
Research Institute ,
Bridgebio Pharma ,
Bio Contact ,
comparemela.com © 2020. All Rights Reserved.